Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
1,653
Views
2
CrossRef citations to date
0
Altmetric
Back Matter

Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions

Erez Nissim Barucha Department of Clinical Immunology and Microbiology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;b The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, IsraelORCID Iconhttps://orcid.org/0000-0001-6001-6598View further author information
ORCID Icon,
Rona Ortenbergb The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, IsraelView further author information
,
Camila Avivic Pathological Institute, Sheba Medical Center, Tel-HaShomer; Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelView further author information
,
Liat Anafic Pathological Institute, Sheba Medical Center, Tel-HaShomer; Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelView further author information
,
Daniela Dick-Neculac Pathological Institute, Sheba Medical Center, Tel-HaShomer; Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelView further author information
,
Chani Stossela Department of Clinical Immunology and Microbiology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;b The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, IsraelView further author information
,
Yonatan Moshkovitsd School of Of Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelView further author information
,
Orit Itzhakib The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, IsraelView further author information
,
Michal Judith Bessera Department of Clinical Immunology and Microbiology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;b The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, IsraelView further author information
,
Jacob Schachterb The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, Israel;d School of Of Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelView further author information
,
Iris Barshackc Pathological Institute, Sheba Medical Center, Tel-HaShomer; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;d School of Of Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelView further author information
&
Gal Markela Department of Clinical Immunology and Microbiology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;b The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, Israel;e Talpiot Medical Leadership Program, Sheba Medical Center, Tel HaShomer, IsraelCorrespondence[email protected]
View further author information
 show all
Article: 1741267 | Received 28 Sep 2019, Accepted 09 Jan 2020, Published online: 25 Mar 2020

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (2)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.